In all communities, relative density of fast-food restaurants linked to modestly increased risk for type 2 diabetes
MONDAY, Nov. 1, 2021 (HealthDay News) — Neighborhood food environment measures are associated with type 2 diabetes, according to a study published online Oct. 29 in JAMA Network Open.
Rania Kanchi, M.P.H., from NYU Langone Health in New York City, and colleagues conducted a national cohort study of 4,100,650 U.S. veterans without type 2 diabetes. Participants entered the cohort between 2008 and 2016 and were followed through 2018 (median, 5.5 person-years). Neighborhood food environment measures were generated based on five-year mean counts of fast-food restaurants and supermarkets relative to other food outlets. The correlation between food environment and time to incident diabetes was examined.
The researchers found that in all community types, the relative density of fast-food restaurants was positively associated with a modestly increased risk for type 2 diabetes. The adjusted hazard ratios were 1.01, 1.01, 1.02, and 1.01 in high-density urban communities, low-density urban communities, suburban communities, and rural communities, respectively. In suburban and rural communities, the relative density of supermarkets was associated with lower type 2 diabetes risk (adjusted hazard ratios, 0.97 and 0.99, respectively).
“Tailored interventions targeting availability of supermarkets may be more appropriate in suburban and rural communities than urban communities, whereas restrictions on fast-food restaurants could possibly help in all community types,” the authors write. “These actions, combined with increasing awareness of the risk of type 2 diabetes and the importance of healthy diet intake, might be associated with a decrease in the burden of type 2 diabetes among adults in the United States.”
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate
Recommendations Issued for Use of Incretin-Based Meds in Pregnancy
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions